Irritable Bowel Syndrome IBS is a lesser version of bowel disorders as it is a gastrointestinal disorder that is characterized by a lack of diagnosable pathology and characterized by abdominal pain and discomfort accompanied by altered bowel habits (Huether & McCance, 2017). The pathophysiology of IBS is unclear. IBS may be related to visceral hypersensitivity, abnormal GI motility, and secretion, intestinal infection, overgrowth of intestinal flora, food allergies or intolerance or psychosocial influences (Huether & McCance, 2017). Unlike IBD, there are no pathological changes in the bowel mucosa. Clinical manifestations are characterized by lower abdominal pain or discomfort. There is no cure for IBS and treatment is on a case-by-case basis. Treatment of symptoms may include laxatives and fiber, antidiarrheals, antispasmodics, prosecretory drugs, low-dose antidepressants, visceral analgesics, and serotonin agonists or antagonists. Alternative therapies include prebiotics and probiotics to manipulate the microflora, hypnosis, acupuncture, yoga, cognitive-behavioral therapy, and dietary interventions (Huether & McCance, 2017). Behavioral Factors Bowel disease is not gender preferential. All three disorders are equally prevalent in men and women. There is an increased risk of irritable bowel syndrome in individuals with anxiety and depression. Regardless of the disease, all are disruptive to the person’s lifestyle. Behavior changes can impact the exacerbations of each disorder. Huether & McCance (2017) mention that relationship with nicotine use and exacerbation with IBD. Cigarette smoking is the most
You've reached the end of your free preview.
Want to read all 3 pages?
- Summer '18
- Gastroenterology, Irritable bowel syndrome, Ulcerative colitis, Crohn's disease, Huether